Contrasting 3M (MMM) and DarioHealth (DRIO)

3M (NYSE:MMM) and DarioHealth (NASDAQ:DRIO) are both multi-sector conglomerates companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, dividends, earnings, profitability, valuation, institutional ownership and analyst recommendations.

Valuation & Earnings

This table compares 3M and DarioHealth’s revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
3M $32.77 billion 3.08 $5.35 billion $10.46 16.76
DarioHealth $7.39 million 4.19 -$17.80 million N/A N/A

3M has higher revenue and earnings than DarioHealth.

Institutional & Insider Ownership

67.2% of 3M shares are owned by institutional investors. Comparatively, 16.8% of DarioHealth shares are owned by institutional investors. 0.8% of 3M shares are owned by insiders. Comparatively, 22.7% of DarioHealth shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Volatility & Risk

3M has a beta of 0.99, meaning that its stock price is 1% less volatile than the S&P 500. Comparatively, DarioHealth has a beta of -1.17, meaning that its stock price is 217% less volatile than the S&P 500.


3M pays an annual dividend of $5.76 per share and has a dividend yield of 3.3%. DarioHealth does not pay a dividend. 3M pays out 55.1% of its earnings in the form of a dividend. 3M has raised its dividend for 60 consecutive years.


This table compares 3M and DarioHealth’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
3M 17.43% 57.42% 15.47%
DarioHealth -240.78% -230.80% -153.84%

Analyst Recommendations

This is a breakdown of current ratings and recommmendations for 3M and DarioHealth, as provided by

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
3M 3 7 3 0 2.00
DarioHealth 0 0 0 0 N/A

3M currently has a consensus price target of $197.08, suggesting a potential upside of 12.44%. Given 3M’s higher possible upside, equities research analysts clearly believe 3M is more favorable than DarioHealth.


3M beats DarioHealth on 11 of the 14 factors compared between the two stocks.

About 3M

3M Company operates as a technology company worldwide. The company's Industrial segment offers tapes, abrasives, adhesives, ceramics, sealants, specialty materials, purification products, closure systems, acoustic systems products, automotive components, abrasion-resistant films, and paint finishing and detailing products. Its Safety and Graphics segment provides personal protection and transportation safety products, commercial graphics systems, commercial cleaning and protection products, floor matting, roofing granules, fall protection products, self-contained breathing apparatus systems, and gas and flame detection instruments. The company's Health Care segment offers medical and surgical supplies, skin health and infection prevention products, drug delivery and health information systems, dental and orthodontic products, and food safety products. Its Electronics and Energy segment provides optical films, packaging and interconnection devices, insulating and splicing solutions, touch screens and monitors, renewable energy component solutions, and infrastructure protection products. The company's Consumer segment offers consumer and office tapes and adhesives, repositionable notes, indexing systems, home improvement products, furnace filters, painter tapes, mounting and home care products, sponges, scouring pads, high-performance clothes, protective material products, and adhesive bandages and braces. It also provides cloud-based, conversational artificial intelligence-powered systems. It serves automotive, electronics and automotive electrification, appliance, paper and printing, packaging, food and beverage, construction, medical clinics and hospitals, pharmaceuticals, dental and orthodontic practitioners, health information systems, food manufacturing and testing, consumer and office retail, office business to business, home improvement, drug and pharmacy retail, and other markets. The company was founded in 1902 and is headquartered in St. Paul, Minnesota.

About DarioHealth

DarioHealth Corp., a digital health company, develops and commercializes patented and proprietary technologies providing consumers with laboratory-testing capabilities using smart phones and other mobile devices in the United States, Europe, Australia, and Canada. The company's flagship product, Dario, also known as Dario Smart Diabetes Management Solution, is a mobile, real-time, cloud-based, diabetes management solution based on a software application combined with Dario Smart Meter, a pocket-sized, blood glucose monitoring device. It offers Dario Engage software platform, where the company digitally engages with Dario users and assists them in monitoring their chronic illnesses, as well as provides them with coaching, support, digital communications, and real time alerts, trends, and pattern analysis. DarioHealth Corp. markets its products directly to consumer cash sales, as well as retail pharmacy and distributors; and through e-stores. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was founded in 2011 and is headquartered in Caesarea, Israel.

Receive News & Ratings for 3M Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 3M and related companies with's FREE daily email newsletter.